Latest Conference Articles

Alopecia Management in Primary Care: Expert Insights from ACP 2025

Alopecia Management in Primary Care: Expert Insights from ACP 2025

April 3rd 2025

ACP

William Lewis, MD, discussed the importance of photo-documentation, referral indicators, efficacy of various treatments, and other topics.

Dermatology in Primary Care: Evidence for the Total Body Skin Exam and Cautions on Cryotherapy

Dermatology in Primary Care: Evidence for the Total Body Skin Exam and Cautions on Cryotherapy

April 3rd 2025

ACP

ACP 2025. A quick look at 2 topics in dermatology rounded out a Multiple Small Feedings of the Mind session at the 2025 American College of Physicians annual meeting.

Prostate Cancer Screening: Balancing Benefits and Harms in an Evolving Landscape

Prostate Cancer Screening: Balancing Benefits and Harms in an Evolving Landscape

April 3rd 2025

ACP

ACP 2025. Ruth Etzioni, PhD, discussed evidence-based approaches to screening for patients at average risk, start and stop criteria, MRI for follow-up screening, and other topics.

ACP: Invest in Rural Communities to Decrease Health Disparities, Improve Access to Care

ACP: Invest in Rural Communities to Decrease Health Disparities, Improve Access to Care

April 3rd 2025

ACP

In a new position paper, the ACP calls for policy action to address rural health disparities, improve access to care, and strengthen the rural health care workforce.

Research That Is Changing Endocrinology: Advances, Challenges, and The Future, with Irl B Hirsch, MD

Research That Is Changing Endocrinology: Advances, Challenges, and The Future, with Irl B Hirsch, MD

April 3rd 2025

ACP

ACP 2025: Irl B Hirsch, MD, reviewed findings from 8 papers published in 2024 that he believes have made or will make a difference in the practice or understanding of the clinical area.

Continuous Glucose Monitoring vs HbA1c: A Deep Dive into CGM Data and How to Use It

Continuous Glucose Monitoring vs HbA1c: A Deep Dive into CGM Data and How to Use It

April 3rd 2025

ACP

ACP 2025. Thomas Martens, MD, Gregg Simonson, PhD, and Libby Johnson, RDN, LD, CDCES explained the benefits of CGM, how to interpret data, and then adjust treatment accordingly.

Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose

Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose

March 28th 2025

AAAAI

Your daily dose of the clinical news you may have missed.

Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose

Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose

March 26th 2025

AAD

Your daily dose of the clinical news you may have missed.

OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose

OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose

March 25th 2025

AAD

Your daily dose of the clinical news you may have missed.

More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal

More Evidence that Women Face Greater CVD Risk than Men, Even When Baseline Health is Equal

March 24th 2025

ACOG

For the same level of baseline health, the increase in risk related to each of 8 key CV risk factors appears significantly higher in women than in men.